Core Viewpoint - The establishment of a national university science and technology park and the biopharmaceutical industry investment conference in Nanjing's Gulou District aims to foster collaboration and innovation in the biopharmaceutical sector, with 20 industry projects signed on-site [1][2]. Group 1: Industry Development - The biopharmaceutical industry is a strategic emerging industry crucial for national economy and public health, serving as an important indicator of regional technological innovation capabilities [2]. - Gulou District has a robust foundation for biopharmaceutical development, featuring 7 medical universities, 11 registered clinical trial institutions, 12 tertiary hospitals, over 460 medical institutions, and more than 600 enterprises in the life and health industry [2]. - The life and health industry in Gulou District generated over 50.9 billion yuan in revenue last year, with large-scale enterprises contributing 17 billion yuan and medical institutions contributing 33.9 billion yuan [2]. Group 2: Collaborative Initiatives - The Nanjing Biopharmaceutical Innovation and Transformation Research Institute, led by China Pharmaceutical University, aims to create a top-tier domestic and international biopharmaceutical achievement transformation platform, with 7 new projects signed for incubation [3]. - The projects include the development of a universal tumor vaccine and an OTC mRNA-LNP nucleic acid drug for liver cancer and fibrosis [3]. Group 3: Infrastructure and Ecosystem - A new national university science and technology park is being established through a partnership between China Pharmaceutical University and Gulou District, focusing on organized research and regional collaboration [4]. - The park will integrate resources from surrounding research institutions, universities, and top-tier hospitals to promote research, technology transfer, industry incubation, financial investment, talent development, and public services [4]. Group 4: Funding and Support - A technology innovation and research transformation alliance has been launched, including major hospitals and institutions in Jiangsu Province [5]. - A biopharmaceutical research and transformation fund has been established, supported by Gulou District, China Pharmaceutical University, and investment firms, aimed at financing biopharmaceutical innovations [5]. - The "Yao Yuan Hui" platform will provide a full lifecycle service system to facilitate the transformation of innovative results [5].